Mary Laughlin - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

Mary Laughlin

Showing results (11-20 of 13) with videos related to

Pageof 2

Sort By:

You have reached the last page of results.This site can display upto 13 results.

Blood|October 21, 2016

Erythropoietin modulation is associated with improved homing and engraftment after umbilical cord blood transplantationOmar S Aljitawi, Soumen Paul, Avishek Ganguly, et al.

Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 29, 2007

Phase II study of enzastaurin, a protein kinase C beta inhibitor, in patients with relapsed or refractory diffuse large B-cell lymphomaMichael J Robertson, Brad S Kahl, Julie M Vose, et al.

Transplantation and Cellular Therapy|July 19, 2022

Characteristics of Graft-Versus-Host Disease (GvHD) After Post-Transplantation Cyclophosphamide Versus Conventional GvHD ProphylaxisRima M Saliba, Amin M Alousi, Joseph Pidala, et al.

Pageof 2

Search research articles

Showing results (11-20 of 13) with videos related to

Sort By:

Pageof 2

You have reached the last page of results.This site can display upto 13 results.

Blood|October 21, 2016

Erythropoietin modulation is associated with improved homing and engraftment after umbilical cord blood transplantationOmar S Aljitawi, Soumen Paul, Avishek Ganguly, et al.

Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 29, 2007

Phase II study of enzastaurin, a protein kinase C beta inhibitor, in patients with relapsed or refractory diffuse large B-cell lymphomaMichael J Robertson, Brad S Kahl, Julie M Vose, et al.

Transplantation and Cellular Therapy|July 19, 2022

Characteristics of Graft-Versus-Host Disease (GvHD) After Post-Transplantation Cyclophosphamide Versus Conventional GvHD ProphylaxisRima M Saliba, Amin M Alousi, Joseph Pidala, et al.

Pageof 2